Liberum acts as Joint Bookrunner on the Merian Chrysalis Investment Company £175m Placing

We are pleased to announce that Liberum acted as Joint Bookrunner on a Placing to raise £175m for Merian Chrysalis. Zeus acted as Joint Bookrunner alongside Liberum.

Image Merian Logo Only RGB 100Mm

The placing will enable the Company's Investment Adviser (Merian Global Investors) to execute on its pipeline of compelling investment opportunities. Approximately 50 per cent. of the proceeds will be used to scale up the Company's exposure to a number of existing portfolio holdings through the acquisition of additional interests in those investments from the Investment Adviser's open-ended UK small- and mid-cap equity funds.

Merian Chrysalis IPOd in November 2018 raising £100m to invest in pre-IPO companies. Since IPO, share price performance has been strong and the Company raised a further £100m through a placing of ordinary shares in April 2019. Following the most recent placing, Liberum has helped the company raise £375m since its IPO.

Liberum Team

Board - David Parsons

Investment Banking - Gillian Martin, Owen Matthews, Louis Davies

Sales - Andrew Davies, Anastasia Mikhailova, Jack Kershaw

CIR - Natalie Clarke

New York


Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY

New York

20th Floor 575 Fifth Avenue New York NY 10017